We need your help fixing hair loss for good

HairDAO is an open-source R&D network where patients and researchers collaborate to develop revolutionary new treatments for hair loss. Log your treatment experiences, contribute to cutting-edge research, and earn HAIR as a reward.

LAUNCH THE APP

8 in 10 men

and half of all women will experience hair loss in their lifetimes.

66% of men

will experience noticeable hair loss before the age of 35.

0 new treatments

have been brought to market since Finasteride in 1997.

0.004%

of all early stage R&D funding goes to hair loss research. That's only $5.4 million a year!

We think patients deserve better

HairDAO is an open-source R&D network where patients and researchers collaborate to develop revolutionary new treatments for hair loss. We believe in the power of a community to tackle big, hairy challenges and make hair loss a thing of the past.

GET INVOLVED

AS SEEN IN

Our research is developed, governed and owned by our community

In our community, the power to decide which research projects receive funding lies with the community members themselves. Both academics and informed community members, who have delved deeply into the relevant literature, are encouraged to propose projects. The ability to vote on which projects should be supported is granted through holding the HAIR token. This democratic approach ensures that a wide range of perspectives are considered in the decision-making process, fostering a diverse and innovative research environment.

TRH

Thyrotropin-releasing Hormone, a neurohormone known for its role in the hypothalmic-pituitary-thyroid axis, has exhibited promising regrowth effects on human hair follicles ex vivo.

PATENT SUBMITTED

T3

Liothyronine, the most potent of the four thyroid hormones, has shown measurable regrowth effects on human scalp skin and human hair follicles ex vivo.

PATENT SUBMITTED

T4

Levothyroxine, the inactive form of Liothyronine, has also exhibited measurable regrowth effects on human scalp skin and human hair follicles ex vivo.

PATENT SUBMITTED

Dutasteride

Dutasteride, the most efficacious hair loss treatment today, comes with a suite of harmful side effects. We seek to eliminate those in our delivery vehicle research.

FUNDED

Twist-1 and 2i

Twist-1 inhibition remains our top protein target. Our study tests 11 Twist inhibitors on human dermal papilla cells and human hair follices in vitro.

FUNDED